Trial
NCT07492875
Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Community-Acquired Pneumonia (CAP)
Intervention
Nogapendekin alfa inbakicept (NAI)
Why stopped
New protocol developed
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-08